These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1806451)

  • 1. Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports.
    Bottini E; Pareti FI; Mari D; Mannucci PM; Muggiasca ML; Conti M
    Haematologica; 1991; 76(5):431-3. PubMed ID: 1806451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill.
    Payne JH; Maclean RM; Hampton KK; Baxter AJ; Makris M
    Haemophilia; 2007 Jan; 13(1):93-7. PubMed ID: 17212732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent massive hemoperitoneum due to ovulation as a clinical sign in congenital afibrinogenemia.
    Cetinkaya SE; Pabuccu EG; Ozmen B; Dokmeci F
    Acta Obstet Gynecol Scand; 2011 Feb; 90(2):192-4. PubMed ID: 21241266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative management of massive hematoperitoneum caused by ovulation in a patient with severe form of von Willebrand disease--a case report.
    Terzic M; Likic I; Pilic I; Bila J; Knezevic N
    Clin Exp Obstet Gynecol; 2012; 39(4):537-40. PubMed ID: 23444764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of ovulation-induced hemoperitoneum by oral contraceptives in a patient with congenital hypoprothrombinemia and in another with congenital factor V deficiency.
    Girolami A; Lombardi AM; Candeo N; Scarparo P; Paternoster A
    Acta Haematol; 2008; 119(4):236-40. PubMed ID: 18583905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital afibrinogenemia: successful prevention of recurrent hemoperitoneum during ovulation by oral contraceptive.
    Castaman G; Ruggeri M; Rodeghiero F
    Am J Hematol; 1995 Aug; 49(4):363-4. PubMed ID: 7639293
    [No Abstract]   [Full Text] [Related]  

  • 7. [Massive hemoperitoneum caused by rupture of the spleen, a complication of congenital afibrinogenemia. Conservative treatment].
    Gallet S; Tran Minh V; Louis D; Cotton JB; Berthier JC; Hartemann E
    Pediatrie; 1985; 40(5):385-91. PubMed ID: 3909095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
    Foster PA
    Thromb Haemost; 1995 Aug; 74(2):784-90. PubMed ID: 8585022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A family with von Willebrand disease and hypofibrinogenemia].
    Shinmyozu K; Okadome T; Maruyama Y; Maruyama I; Osame M
    Rinsho Ketsueki; 1990 Sep; 31(9):1463-7. PubMed ID: 2246818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I von Willebrand's disease presenting as recurrent corpus hemorrhagicum.
    Jarvis RR; Olsen ME
    Obstet Gynecol; 2002 May; 99(5 Pt 2):887-8. PubMed ID: 11975946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand's disease.
    Gomez A; Lucia JF; Perella M; Aguilar C
    Haemophilia; 1998 Jan; 4(1):60-2. PubMed ID: 9873868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital afibrinogenemia: treatment of excessive menstrual bleeding with continuous oral contraceptive.
    Rizk DE; Kumar RM
    Am J Hematol; 1996 Jul; 52(3):237-8. PubMed ID: 8756102
    [No Abstract]   [Full Text] [Related]  

  • 14. Von Willebrand disease and recurrent hematoperitoneum due to the rupture of haemorrhagic ovarian cysts.
    Radakovic B; Grgic O
    Haemophilia; 2009 Mar; 15(2):607-9. PubMed ID: 19187196
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ovarian bleeding in patients with congenital bleeding tendency].
    Takamatsu J; Hamaguchi M; Kagami K; Suehiro K; Okumura M; Kojima T; Saito H
    Rinsho Ketsueki; 1988 Nov; 29(11):2037-41. PubMed ID: 3266258
    [No Abstract]   [Full Text] [Related]  

  • 16. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with ectopic pregnancy with massive hemoperitoneum by laparoscopic surgery with intraoperative autologous blood transfusion.
    Takeda A; Manabe S; Mitsui T; Nakamura H
    J Minim Invasive Gynecol; 2006; 13(1):43-8. PubMed ID: 16431322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent haemoperitoneum in a mild von Willebrand's disease combined with a storage pool deficit.
    Meschengieser SS; Alberto MF; Salviú J; Bermejo E; Lazzari MA
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):207-9. PubMed ID: 11414635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unusual cause for the development of hemoperitoneum].
    Chovanec M; Chlapik D; Lipenský S; Samsula M
    Zentralbl Gynakol; 1986; 108(18):1140-3. PubMed ID: 3788343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corpus luteum hemorrhage: rare complication of congenital and acquired coagulation abnormalities.
    Gupta N; Dadhwal V; Deka D; Jain SK; Mittal S
    J Obstet Gynaecol Res; 2007 Jun; 33(3):376-80. PubMed ID: 17578371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.